STOCK TITAN

GRAIL to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

GRAIL (Nasdaq: GRAL) has announced its participation in two upcoming investor conferences. The company will conduct fireside chats at the Piper Sandler 36th Annual Healthcare Conference in New York on December 3 at 1:30 p.m. ET, and at the 7th Annual Evercore ISI HealthCONx Conference in Coral Gables, Florida on December 4 at 3:50 p.m. ET. Both sessions will be available via webcast on GRAIL's investor relations website, with replays accessible for at least 30 days following the events.

GRAIL (Nasdaq: GRAL) ha annunciato la sua partecipazione a due imminenti conferenze per investitori. L'azienda condurrà discussioni al 36° Annual Healthcare Conference di Piper Sandler a New York il 3 dicembre alle 13:30 ET, e al 7° Annual Evercore ISI HealthCONx Conference a Coral Gables, Florida, il 4 dicembre alle 15:50 ET. Entrambi gli incontri saranno disponibili tramite webcast sul sito delle relazioni con gli investitori di GRAIL, con repliche accessibili per almeno 30 giorni dopo gli eventi.

GRAIL (Nasdaq: GRAL) ha anunciado su participación en dos próximas conferencias para inversores. La compañía llevará a cabo charlas en el 36º Annual Healthcare Conference de Piper Sandler en Nueva York el 3 de diciembre a la 1:30 p.m. ET, y en el 7º Annual Evercore ISI HealthCONx Conference en Coral Gables, Florida, el 4 de diciembre a las 3:50 p.m. ET. Ambas sesiones estarán disponibles a través de webcast en el sitio web de relaciones con inversores de GRAIL, con repeticiones accesibles por al menos 30 días después de los eventos.

GRAIL (Nasdaq: GRAL)은 두 개의 다가오는 투자자 회의에 참여할 것이라고 발표했습니다. 이 회사는 12월 3일 오후 1시 30분 ET에 뉴욕에서 열리는 파이퍼 샌들러 제36회 연례 의료 회의와 12월 4일 오후 3시 50분 ET에 플로리다주 코럴 게이블스에서 열리는 제7회 에버코어 ISI HealthCONx 회의에서 대화형 세션을 진행할 예정입니다. 두 세션 모두 GRAIL의 투자자 관계 웹사이트에서 웹캐스트로 제공되며, 이벤트 후 최소 30일 동안 다시 볼 수 있습니다.

GRAIL (Nasdaq: GRAL) a annoncé sa participation à deux prochaines conférences pour investisseurs. L'entreprise animera des discussions lors de la 36e conférence annuelle sur la santé de Piper Sandler à New York le 3 décembre à 13h30 ET, et lors de la 7e conférence HealthCONx d'Evercore ISI à Coral Gables, en Floride, le 4 décembre à 15h50 ET. Les deux sessions seront disponibles via un webinaire sur le site Web des relations investisseurs de GRAIL, avec des rediffusions accessibles pendant au moins 30 jours après les événements.

GRAIL (Nasdaq: GRAL) hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen bekannt gegeben. Das Unternehmen wird Gesprächsrunden auf der 36. jährlichen Healthcare-Konferenz von Piper Sandler in New York am 3. Dezember um 13:30 Uhr ET und auf der 7. jährlichen Evercore ISI HealthCONx-Konferenz in Coral Gables, Florida, am 4. Dezember um 15:50 Uhr ET durchführen. Beide Sitzungen werden über einen Webcast auf der Investor-Relations-Website von GRAIL verfügbar sein, mit Wiederholungen, die für mindestens 30 Tage nach den Veranstaltungen zugänglich sind.

Positive
  • None.
Negative
  • None.

MENLO PARK, Calif., Nov. 19, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will participate in the following investor conferences.

  • Piper Sandler 36th Annual Healthcare Conference in New York, NY: fireside chat on Tuesday, Dec. 3 at 1:30 p.m. ET
  • 7th Annual Evercore ISI HealthCONx Conference in Coral Gables, Fla.: fireside chat on Wednesday, Dec. 4 at 3:50 p.m. ET

Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after the event.

About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom.
For more information, visit grail.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-participate-in-upcoming-investor-conferences-302310482.html

SOURCE GRAIL, Inc.

FAQ

When is GRAIL (GRAL) presenting at the Piper Sandler Healthcare Conference 2024?

GRAIL (GRAL) will present at the Piper Sandler Healthcare Conference on December 3, 2024, at 1:30 p.m. ET in New York.

Where can I watch GRAIL's (GRAL) investor conference webcasts?

GRAIL's investor conference webcasts can be accessed through the investor relations section of GRAIL's website at investors.grail.com, with replays available for 30 days after each event.

What investor conferences is GRAIL (GRAL) attending in December 2024?

GRAIL is attending the Piper Sandler 36th Annual Healthcare Conference in New York and the 7th Annual Evercore ISI HealthCONx Conference in Coral Gables, Florida.

What time is GRAIL's (GRAL) presentation at the Evercore ISI HealthCONx Conference?

GRAIL will present at the Evercore ISI HealthCONx Conference on December 4, 2024, at 3:50 p.m. ET in Coral Gables, Florida.

GRAIL, Inc.

NASDAQ:GRAL

GRAL Rankings

GRAL Latest News

GRAL Stock Data

616.47M
28.98M
13.75%
67.1%
11.25%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
MENLO PARK